Publicacións nas que colabora con José María de la Torre Hernández (22)

2024

  1. A Prospective, Multicenter, Real-World Registry of Coronary Lithotripsy in Calcified Coronary Arteries: The REPLICA-EPIC18 Study

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 756-767

  2. Impact of the COVID-19 Pandemic on Global TAVR Activity: The COVID-TAVI Study

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 3, pp. 374-387

2023

  1. Trends in cardiovascular care in the National Health System in Spain. Data from the RECALCAR project 2011-2020

    Revista Espanola de Cardiologia, Vol. 76, Núm. 7, pp. 519-530

2022

  1. Design and Rationale for a Real-World Prospective, Multicenter Registry of Myocardial Revascularization Failure and Secondary Revascularization: The REVASEC Study

    Cardiovascular Revascularization Medicine, Vol. 40, pp. 50-56

  2. Early clinical outcomes after transaxillary versus transfemoral TAVI. Data from the Spanish TAVI registry

    Revista Espanola de Cardiologia, Vol. 75, Núm. 6, pp. 479-487

  3. Justificación y diseño del estudio Concordancia entre RFF e iFR en lesiones del tronco común.: Estudio iLITRO-EPIC-07

    REC: Interventional Cardiology, Vol. 4, Núm. 1, pp. 19-26

  4. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

  5. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)

    European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301

  6. Stents recubiertos o farmacoactivos en aneurismas, resultados del Registro Internacional de Aneurismas Coronarios (CAAR)

    REC: Interventional Cardiology, Vol. 4, Núm. 2, pp. 107-114

2021

  1. Aplicación prospectiva de un protocolo antitrombótico ajustado a riesgo isquémico/hemorrágico en pacientes mayores de 75 años tratados con stents liberadores de everolimus: Registro SIERRA-75 (EPIC-05)

    REC: Interventional Cardiology, Vol. 3, Núm. 4, pp. 15-15

  2. Outcomes of predefined optimisation criteria for intravascular ultrasound guidance of left main stenting

    EuroIntervention, Vol. 16, Núm. 3, pp. 210-217

2020

  1. Efectos de la pandemia de COVID-19 sobre la población mayor de 75 años con revascularización coronaria previa: Subanálisis del registro EPIC SIERRA 75

    REC: Interventional Cardiology, Vol. 2, Núm. 4, pp. 321-322

2019

  1. Baseline Risk Stratification of Patients Older Than 75 Years With Infarction and Cardiogenic Shock Undergoing Primary Angioplasty

    Revista Espanola de Cardiologia, Vol. 72, Núm. 12, pp. 1005-1011

2018

  1. Multivessel disease in patients over 75 years old with ST elevated myocardial infarction. Current management strategies and related clinical outcomes in the ESTROFA MI + 75 nation-wide registry

    Cardiovascular Revascularization Medicine, Vol. 19, Núm. 5, pp. 580-588

  2. Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite® drug-eluting stent: The ANCHOR study

    Catheterization and Cardiovascular Interventions, Vol. 91, Núm. 3, pp. 435-443

2017

  1. Angioplastia primaria en mayores de 75 años. Perfil de pacientes y procedimientos, resultados y predictores pronósticos en el registro ESTROFA IM + 75

    Revista Espanola de Cardiologia, Vol. 70, Núm. 2, pp. 81-87

2016

  1. Interhospital Variability in Drug Prescription after Acute Coronary Syndrome: Insights from the ACDC Study

    Revista Espanola de Cardiologia, Vol. 69, Núm. 2, pp. 117-124

2014

  1. A prospective randomized trial of everolimus-eluting stents versus bare-metal stents in octogenarians: The XIMA trial (xience or vision stents for the management of angina in the elderly)

    Journal of the American College of Cardiology, Vol. 63, Núm. 14, pp. 1371-1375

  2. Response to letter regarding article, "effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: The effect of metoprolol in cardioprotection during an acute myocardial infarction (METOCARD-CNIC) trial"

    Circulation

2013

  1. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: The effect of Metoprolol in Cardioprotection during an Acute Myocardial Infarction (METOCARD-CNIC) Trial

    Circulation, Vol. 128, Núm. 14, pp. 1495-1503